Expression Pattern of Selected Toll-like Receptors (TLR’s) in the PBMC’s of Severe and Non-severe Dengue Cases

References

• Akira S, Uematsu S, Takeuchi O. (2006). Pathogen recognition and innate immunity. Cell, 124(4), 783–801. doi:10.1016/j.cell.2006.02.015
   PubMed Web of Science ®Google Scholar
• Cavalcanti LP, de G, Mota LAM, et al. (2014). Evaluation of the WHO classification of dengue disease severity during an epidemic in 2011 in the state of Ceará, Brazil. Mem Inst Oswaldo Cruz, 109(1), 93–98. doi:10.1590/0074-0276140384
   PubMed Web of Science ®Google Scholar
• Chang S, Dolganiuc A, Szabo G. (2007). Toll-like receptors 1 and 6 are involved in TLR2-mediated macrophage activation by hepatitis C virus core and NS3 proteins. J Leukoc Biol, 82(3), 479–487. doi:10.1189/jlb.0207128
   PubMed Web of Science ®Google Scholar
• Chen J, Ng MML, Chu JJH. (2008). Molecular profiling of T-helper immune genes during dengue virus infection. Virol J, 5(1), 165. doi:10.1186/1743-422X-5-165
   PubMed Web of Science ®Google Scholar
• Chen J, Ng MM-L, Chu JJH. (2015). Activation of TLR2 and TLR6 by dengue NS1 protein and its implications in the immunopathogenesis of dengue virus infection. PLoS Pathog, 11(7), e1005053. doi:10.1371/journal.ppat.1005053
   PubMed Web of Science ®Google Scholar
• Cherupanakkal C, Ramachadrappa V, Kadhiravan T, et al. (2017a). A study on gene expression profile of endogenous antioxidant enzymes: CAT, MnSOD and GPx in dengue patients. Indian J Clin Biochem, 32(4), 437–445. doi:10.1007/s12291-017-0633-x
   PubMed Web of Science ®Google Scholar
• Cherupanakkal C, Ramachadrappa V, Kadhiravan T, et al. (2017b). Differential expression of NADPH oxidase-2 (Nox-2) and nuclear factor-erythroid 2-related factor 2 (Nrf2) transcripts in peripheral blood mononuclear cells isolated from dengue patients. VirusDisease, 28(1), 54–60. doi:10.1007/s13337-017-0365-9
   PubMedGoogle Scholar
• Cherupanakkal C, Samadanam DM, Muthuraman KR, et al. (2018). Lipid peroxidation, DNA damage, and apoptosis in dengue fever. IUBMB Life, 70, 1133–1143. doi:10.1002/iub.1928
   PubMed Web of Science ®Google Scholar
• Cook DN, Pisetsky DS, Schwartz DA. (2004). Toll-like receptors in the pathogenesis of human disease. Nat Immunol, 5(10), 975–979. doi:10.1038/ni1116
   PubMed Web of Science ®Google Scholar
• Halstead SB, Lum LC. (2009). Assessing the prognosis of dengue-infected patients. F1000 Med Rep, 1, 73.
   PubMedGoogle Scholar
• Hoang LT, Lynn DJ, Henn M, et al. (2010). The early whole-blood transcriptional signature of dengue virus and features associated with progression to dengue shock syndrome in vietnamese children and young adults. J Virol, 84(24), 12982–12994. doi:10.1128/JVI.01224-10
   PubMed Web of Science ®Google Scholar
• Hou B, Reizis B, DeFranco AL. (2008). Toll-like receptors activate innate and adaptive immunity by using dendritic cell-intrinsic and -extrinsic mechanisms. Immunity, 29(2), 272–282. doi:10.1016/j.immuni.2008.05.016
   PubMed Web of Science ®Google Scholar
• Ioannidis I, Ye F, McNally B, et al. (2013). Toll-like receptor expression and induction of Type I and Type III interferons in primary airway epithelial cells. J Virol, 87(6), 3261–3270. doi:10.1128/JVI.01956-12
   PubMed Web of Science ®Google Scholar
• Khurram M, Qayyum W, Hassan SJU, et al. (2014). Dengue hemorrhagic fever: comparison of patients with primary and secondary infections. J Infect Public Health, 7(6), 489–495. doi:10.1016/j.jiph.2014.05.005
   PubMed Web of Science ®Google Scholar
• Kumar VE, Cherupanakkal C, Catherine M, et al. (2018). Endogenous gene selection for relative quantification PCR and IL6 transcript levels in the PBMC’s of severe and non-severe dengue cases. BMC Res Notes, 11(1), 550.
   PubMedGoogle Scholar
• Lai J-H, Wang M-Y, Huang C-Y, et al. (2018). Infection with the dengue RNA virus activates TLR9 signaling in human dendritic cells. EMBO Rep, 19(8), pii: e46182.
   Web of Science ®Google Scholar
• Lai Y, Xue C, Liao Y, et al. (2017). Differential expression of toll-like receptor signaling pathway is associated with microscopic polyangiitis in peripheral blood neutrophils. Immunol Invest, 46(3), 375–384. doi:10.1080/08820139.2016.1267204
   PubMed Web of Science ®Google Scholar
• Le Goffic R, Pothlichet J, Vitour D, et al. (2007). Cutting edge: influenza a virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells. J Immunol Baltim Md 1950, 178, 3368–3372.
   Google Scholar
• Livak KJ, Schmittgen TD. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods San Diego Calif, 25(4), 402–408. doi:10.1006/meth.2001.1262
   PubMed Web of Science ®Google Scholar
• Murray NEA, Quam MB, Wilder-Smith A. (2013). Epidemiology of dengue: past, present and future prospects. Clin Epidemiol, 5, 299–309.
   PubMedGoogle Scholar
• Naka K, Dansako H, Kobayashi N, et al. (2006). Hepatitis C virus NS5B delays cell cycle progression by inducing interferon-β via Toll-like receptor 3 signaling pathway without replicating viral genomes. Virology, 346(2), 348–362. doi:10.1016/j.virol.2005.10.023
   PubMed Web of Science ®Google Scholar
• Narvaez F, Gutierrez G, Pérez MA, et al. (2011). Evaluation of the traditional and revised WHO classifications of dengue disease severity. PLoS Negl Trop Dis, 5, e1397. doi:10.1371/journal.pntd.0001370
   PubMed Web of Science ®Google Scholar
• Nasirudeen AMA, Wong HH, Thien P, et al. (2011). RIG-I, MDA5 and TLR3 synergistically play an important role in restriction of dengue virus infection. PLoS Negl Trop Dis, 5, e926. doi:10.1371/journal.pntd.0001370
   PubMed Web of Science ®Google Scholar
• O’Neill LAJ. (2003). Therapeutic targeting of Toll-like receptors for inflammatory and infectious diseases. Curr Opin Pharmacol, 3(4), 396–403. doi:10.1016/S1471-4892(03)00080-8
   PubMed Web of Science ®Google Scholar
• Pal T, Dutta SK, Mandal S, et al. (2014). Differential clinical symptoms among acute phase Indian patients revealed significant association with dengue viral load and serum IFN-gamma level. J Clin Virol Off Publ Pan Am Soc Clin Virol, 61(3), 365–370. doi:10.1016/j.jcv.2014.09.003
   Web of Science ®Google Scholar
• Parthasarathy D, Madhuravasal JK, Jayavel P, et al. (2018). Expression analysis of toll-like receptors of dengue-infected cornea by real-time polymerase chain reaction. Inflamm Res Off J Eur Histamine Res Soc Al, 67, 555–558.
   Google Scholar
• Sanaei R, Rezaei N, Aghamohammadi A, et al. (2019). Disturbed transcription of TLRs’ negative regulators and cytokines secretion among TLR4- and 9-activated PBMCs of agammaglobulinemic patients. Immunol Invest, 1–15. doi:10.1080/08820139.2019.1604742
   PubMed Web of Science ®Google Scholar
• Sato A, Linehan MM, Iwasaki A. (2006). Dual recognition of herpes simplex viruses by TLR2 and TLR9 in dendritic cells. Proc Natl Acad Sci, 103(46), 17343–17348. doi:10.1073/pnas.0605102103
   PubMed Web of Science ®Google Scholar
• Soundravally R, Hoti SL, Patil SA, et al. (2014). Association between proinflammatory cytokines and lipid peroxidation in patients with severe dengue disease around defervescence. Int J Infect Dis IJID Off Publ Int Soc Infect Dis, 18, 68–72.
   PubMed Web of Science ®Google Scholar
• Sprokholt J, Helgers LC, Geijtenbeek TB. (2018). Innate immune receptors drive dengue virus immune activation and disease. Future Virol, 13(4), 287–305. doi:10.2217/fvl-2017-0146
   Web of Science ®Google Scholar
• Takeda K, Akira S. (2005). Toll-like receptors in innate immunity. Int Immunol, 17(1), 1–14. doi:10.1093/intimm/dxh186
   PubMed Web of Science ®Google Scholar
• TDR. (2009). Dengue - guidelines for diagnosis, treatment, prevention and control [Internet]. WHO. [cited 2018 Sep 12]. Available from: http://www.who.int/tdr/publications/training-guideline-publications/dengue-diagnosis-treatment/en/
   Google Scholar
• Thompson MR, Kaminski JJ, Kurt-Jones EA, Fitzgerald KA. (2011). Pattern recognition receptors and the innate immune response to viral infection. Viruses, 3(6), 920–940. doi:10.3390/v3060920
   PubMed Web of Science ®Google Scholar
• Torres S, Hernández JC, Giraldo D, et al. (2013). Differential expression of toll-like receptors in dendritic cells of patients with dengue during early and late acute phases of the disease. PLoS Negl Trop Dis, 7(2), e2060.
   PubMed Web of Science ®Google Scholar
• Trinchieri G, Sher A. (2007). Cooperation of toll-like receptor signals in innate immune defence. Nat Rev Immunol, 7(3), 179–190. doi:10.1038/nri2038
   PubMed Web of Science ®Google Scholar
• Troutman TD, Bazan JF, Pasare C. (2012). Toll-like receptors, signaling adapters and regulation of the pro-inflammatory response by PI3K. Cell Cycle, 11(19), 3559–3567. doi:10.4161/cc.21572
   PubMed Web of Science ®Google Scholar
• Tsai Y-T, Chang S-Y, Lee C-N, Kao C-L. (2009). Human TLR3 recognizes dengue virus and modulates viral replication in vitro. Cell Microbiol, 11(4), 604–615. doi:10.1111/cmi.2009.11.issue-4
   PubMed Web of Science ®Google Scholar
• Wang W-K, Chen H-L, Yang C-F, et al. (2006). Slower rates of clearance of viral load and virus-containing immune complexes in patients with dengue hemorrhagic fever. Clin Infect Dis Off Publ Infect Dis Soc Am, 43(8), 1023–1030. doi:10.1086/cid.2006.43.issue-8
   PubMed Web of Science ®Google Scholar
• WHO. (2019). Dengue and severe dengue [Internet]. [cited 2019 Mar 17]. Available from: https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue
   Google Scholar
• Wilder-Smith A, Ooi -E-E, Vasudevan SG, Gubler DJ. (2010). Update on dengue: epidemiology, virus evolution, antiviral drugs, and vaccine development. Curr Infect Dis Rep, 12(3), 157–164. doi:10.1007/s11908-010-0102-7
   PubMedGoogle Scholar